Order Article Reprints

Gong L, Zhao H, Chen L, Liu Y, Wu H, Liu C, Feng J, Liu C, Xiao C, Wang Q, et al. Novel Peptide-Modified Zeolitic Imidazolate Framework-8 Nanoparticles with pH-Sensitive Release of Doxorubicin for Targeted Treatment of Colorectal Cancer. Pharmaceutics. 2025; 17(2):246. https://doi.org/10.3390/pharmaceutics17020246

Gong, Liming, Heming Zhao, Liqing Chen, Yanhong Liu, Hao Wu, Chao Liu, Jing Feng, Chenfei Liu, Congcong Xiao, Qiming Wang, and et al. 2025. "Novel Peptide-Modified Zeolitic Imidazolate Framework-8 Nanoparticles with pH-Sensitive Release of Doxorubicin for Targeted Treatment of Colorectal Cancer" Pharmaceutics 17, no. 2: 246. https://doi.org/10.3390/pharmaceutics17020246

Gong, L., Zhao, H., Chen, L., Liu, Y., Wu, H., Liu, C., Feng, J., Liu, C., Xiao, C., Wang, Q., Jin, M., Gao, Z., Huang, W., & Guan, Y. (2025). Novel Peptide-Modified Zeolitic Imidazolate Framework-8 Nanoparticles with pH-Sensitive Release of Doxorubicin for Targeted Treatment of Colorectal Cancer. Pharmaceutics, 17(2), 246. https://doi.org/10.3390/pharmaceutics17020246